Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus – a randomized study using positron emission tomography

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetic Medicine

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-5491.2004.01371.xPMID 15660732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus

  2002cited by this paper
• Microcirculatory effects of KATP channel blockade by sulphonylurea derivatives in humans

  2002cited by this paper
• Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus

  2002cited by this paper
• Peripheral Flow Response to Transient Arterial Forearm Occlusion Does Not Reflect Myocardial Perfusion Reserve

  2001cited by this paper
• Improved endothelial function with metformin in type 2 diabetes mellitus.

  2001cited by this paper
• Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes

  2001cited by this paper
• Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia

  2001cited by this paper
• Pancreatic β-Cell KATP Channel Activity and Membrane-Binding Studies with Nateglinide: A Comparison with Sulfonylureas and Repaglinide

  2000cited by this paper
• A new look at the heart in diabetes mellitus: from ailing to failing

  2000cited by this paper
• Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

  2000cited by this paper
• Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy.

  2000cited by this paper
• Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.

  1999cited by this paper
• Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and β-Cell KATP Channels

  1999cited by this paper
• Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus.

  1999cited by this paper
• Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin.

  1999cited by this paper
• Hyperglycemia Rather Than Insulin Resistance Is Related to Reduced Coronary Flow Reserve in NIDDM

  1998cited by this paper
• Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity.

  1998cited by this paper
• Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo.

  1998cited by this paper
• Preserved Endothelial Function in IDDM Patients, but Not in NIDDM Patients, Compared With Healthy Subjects

  1998cited by this paper
• Coronary Flow Reserve Is Reduced in Young Men With IDDM

  1998cited by this paper
• Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography

  1998cited by this paper
• Myocardial blood flow and glucose metabolism in diabetes mellitus.

  1997cited by this paper
• Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel.

  1997cited by this paper
• Cardiovascular effects of sulphonylurea derivatives

  1997cited by this paper
• Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited.

  1997cited by this paper
• Comparison between positron emission tomography myocardial perfusion imaging and intracoronary Doppler flow velocity measurements at rest and during cold pressor testing in angiographically normal coronary arteries in patients with one-vessel coronary artery disease.

  1996cited by this paper
• Cardiovascular effects of sulphonylurea derivatives

  1996cited by this paper
• Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs.

  1995cited by this paper
• Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM?

  1995cited by this paper
• Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.

  1994cited by this paper
• Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function

  1993cited by this paper
• Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET.

  1993cited by this paper
• Pharmacological Evidence for a Role of ATP‐Dependent Potassium Channels in Myocardial Stunning

  1992cited by this paper

• Features of postoperative therapy in patients with type ІІ diabetes

  2020cites this paper
• Treatment strategies in coronary microvascular dysfunction: A systematic review of interventional studies

  2019cites this paper
• Quantitative analysis of coronary endothelial function with generator-produced rubidium- 82 PET - Comparison with oxygen 15-labeled water PET-

  2017cites this paper
• Comprehensive assessment of impaired peripheral and coronary artery endothelial functions in smokers using brachial artery ultrasound and oxygen-15-labeled water PET.

  2016cites this paper
• Direct 4D Parametric Imaging in Dynamic Myocardial Perfusion PET

  2015cites this paper
• Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease.

  2014cites this paper
• On the potential of acarbose to reduce cardiovascular disease

  2014cites this paper
• Quantitation of Myocardial Perfusion: Absolute Blood Flow Versus Relative Uptake

  2013cites this paper
• Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation

  2012cites this paper
• Quantitative Cardiac Positron Emission Tomography: The Time Is Coming!

  2012influential citation
• Endothelial Dysfunction and Therapeutic Intervention in Type 2 Diabetes

  2011cites this paper
• Assessment of coronary endothelial function using PET

  2011cites this paper
• Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET

  2010cites this paper
• Coronary vasomotor function assessed by positron emission tomography

  2010cites this paper
• Chapter 33 – Myocardial Blood Flow Measurement: Evaluating Coronary Pathophysiology and Monitoring Therapy

  2010cites this paper
• Quantification of Myocardial Blood Flow Using Rubidium-82 PET

  2010cites this paper
• Cardiac positron emission tomography.

  2009cites this paper
• A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study

  2009cites this paper
• Disturbances in myocardial diastolic and vascular function with the emphasis on type 2 diabetes : Diagnostic and therapeutic opportunities

  2009cites this paper
• Present and future of clinical cardiovascular PET imaging in Europe—a position statement by the European Council of Nuclear Cardiology (ECNC)

  2008cites this paper
• Meglitinide analogues for type 2 diabetes mellitus.

  2007cites this paper
• Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with 13N-ammonia and PET

  2007cites this paper
• Endothelial dysfunction in diabetes mellitus

  2007cites this paper
• Meglitinide analogues: a review of clinical data focused on recent trials.

  2006cites this paper